Viewing Protocol Section

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT05807126
Ignite Creation Date: 2024-05-06 @ 6:51 PM
Last Modification Date: 2024-10-26 @ 2:56 PM
Study NCT ID: NCT05807126
Protocol Section: NCT05807126
Start Identification Module Data
Expand Identification Module Data
Brief Title: Testing the Addition of Immunotherapy With Hu5F9-G4 Magrolimab to the Usual PARP Inhibitor Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations
Official Title: A Phase IIb Study of Anti-CD47 Hu5F9-G4 Magrolimab in Combination With Olaparib in Patients With BRCA12-Mutant Tumors
Acronym: None
Organization: National Cancer Institute NCI
Organization Class: NIH
Organization Study ID: NCI-2023-02710
Secondary IDs
Secondary ID Type Domain Link
NCI-2023-02710 REGISTRY None None
10551 OTHER None None
10551 OTHER None None
UM1CA186690 NIH CTEP httpsreporternihgovquickSearchUM1CA186690
Start Status Module Data
Status Verified Date: 2024-04
Overall Status: WITHDRAWN
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: National Cancer Institute NCI
Lead Sponsor Class: NIH
Lead Sponsor: National Cancer Institute NCI
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload